Management of chronic insomnia disorder in adults: A clinical practice guideline from the American college of physicians

Annals of Internal Medicine

Volumn 165, Issue 2, 2016, Pages 125-133

  Qaseem, Amir ^a   Kansagara, Devan ^b   Forciea, Mary Ann ^c   Cooke, Molly ^d   Denberg, Thomas D ^e   Barry, Michael J ^f   Boyd, Cynthia ^f   Chow, R Dobbin ^f   Fitterman, Nick ^f   Harris, Russell P ^f   Humphrey, Linda L ^f   Manaker, Scott ^f   McLean, Robert ^f   Mir, Tanveer P ^f   Schünemann, Holger J ^f   Vijan, Sandeep ^f   Wilt, Timothy ^f  

^a AMERICAN COLLEGE OF PHYSICIANS   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c Department of Hepatology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CARILION CLINIC   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DOXEPIN; ESTAZOLAM; ESZOPICLONE; FLURAZEPAM; HYPNOTIC AGENT; MELATONIN; NEUROLEPTIC AGENT; QUAZEPAM; RAMELTEON; SUVOREXANT; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM;

ACCIDENTAL INJURY; ADVERSE OUTCOME; AMNESIA; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BLURRED VISION; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONSTIPATION; DEMENTIA; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FRACTURE; HALLUCINATION; HEAD INJURY; HEADACHE; HIP FRACTURE; HUMAN; INSOMNIA; LETHARGY; MEMORY DISORDER; MOOD DISORDER; MYALGIA; NAUSEA; PARASOMNIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; SOMNOLENCE; SUICIDAL IDEATION; SYSTEMATIC REVIEW; THERAPY EFFECT; UNPLEASANT SENSATION; WALKING DIFFICULTY; WEAKNESS; XEROSTOMIA; ADULT; DECISION MAKING; DRUG COST; PSYCHOLOGY; RISK ASSESSMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADULT; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS RESEARCH; DECISION MAKING; DRUG COSTS; HUMANS; RISK ASSESSMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84979641049     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2175     Document Type: Article

References (80)

1. American Psychiatric Association. Sleep-Wake Disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Association; 2013.
2. Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379:1129-41. [PMID: 22265700] doi:10.1016/S0140-6736(11)60750-2
3. Insomnia. DynaMed Web site. Accessed at www.dynamed.com/home on 5 December 2015.
4. Buysse DJ. Insomnia. JAMA. 2013;309:706-16. [PMID: 23423416] doi:10.1001/jama.2013.193
5. Xu M, Bélanger L, Ivers H, Guay B, Zhang J, Morin CM. Comparison of subjective and objective sleep quality in menopausal and non-menopausal women with insomnia. Sleep Med. 2011;12:65-9. [PMID: 21147026] doi:10.1016/j.sleep.2010.09.003
6. Rybarczyk B, Lund HG, Garroway AM, Mack L. Cognitive behavioral therapy for insomnia in older adults: background, evidence, and overview of treatment protocol. Clin Gerontol. 2013;36:70-93. doi:10.1080/07317115.2012.731478
7. Kraus SS, Rabin LA. Sleep America: managing the crisis of adult chronic insomnia and associated conditions. J Affect Disord. 2012; 138:192-212. [PMID: 21652083] doi:10.1016/j.jad.2011.05.014
8. Kessler RC, Berglund PA, Coulouvrat C, Hajak G, Roth T, Shahly V, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011;34:1161-71. [PMID: 21886353] doi:10.5665/SLEEP.1230
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Association; 2013.
10. American Academy of Sleep Medicine. The International Classification of Sleep Disorders-Third Edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine; 2014.
11. Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165:103-12. doi:10.7326/M15-1781
12. Brasure M, Fuchs E, MacDonald R, Nelson VA, Koffel E, Olson CM, et al. Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016; 165:113-24. doi:10.7326/M15-1782
13. Brasure M, MacDonald R, Fuchs E, Olson CM, Carlyle M, Diem S, et al. Management of Insomnia Disorder. Comparative Effectiveness Review 159. (Prepared by the Minnesota Evidence-based Practice Center under contract 290-2012-00016-I.) AHRQ Publication no. 15(16)-EHC027-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2015. Accessed at www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=2164 on 29 March 2016.
14. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010;153:194-9. [PMID: 20679562] doi:10.7326/0003-4819-153-3-201008030-00010
15. Bothelius K, Kyhle K, Espie CA, Broman JE. Manual-guided cognitive-behavioural therapy for insomnia delivered by ordinary primary care personnel in general medical practice: a randomized controlled effectiveness trial. J Sleep Res. 2013;22:688-96. [PMID: 23859625] doi:10.1111/jsr.12067
16. Jernelöv S, Lekander M, Blom K, Rydh S, Ljótsson B, Axelsson J, et al. Efficacy of a behavioral self-help treatment with or without therapist guidance for co-morbid and primary insomnia-a randomized controlled trial. BMC Psychiatry. 2012;12:5. [PMID: 22264332] doi:10.1186/1471-244X-12-5
17. Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry. 2009;66: 692-8. [PMID: 19581560] doi:10.1001/archgenpsychiatry.2009.66
18. Edinger JD, Sampson WS. A primary care "friendly" cognitive behavioral insomnia therapy. Sleep. 2003;26:177-82. [PMID: 12683477]
19. Espie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007;30:574-84. [PMID: 17552372]
20. Jansson M, Linton SJ. Cognitive-behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. J Occup Rehabil. 2005;15:177-90. [PMID: 15844675]
21. Arnedt JT, Cuddihy L, Swanson LM, Pickett S, Aikens J, Chervin RD. Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia. Sleep. 2013;36:353-62. [PMID: 23450712] doi:10.5665/sleep.2448
22. Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35:769-81. [PMID: 22654196] doi:10.5665/sleep.1872
23. StrömL, Pettersson R, Andersson G. Internet-based treatment for insomnia: a controlled evaluation. J Consult Clin Psychol. 2004;72: 113-20. [PMID: 14756620]
24. Edinger JD, Olsen MK, Stechuchak KM, Means MK, Lineberger MD, Kirby A, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep. 2009;32:499-510. [PMID: 19413144]
25. Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep. 2009;32:807-15. [PMID: 19544758]
26. Mimeault V, Morin CM. Self-help treatment for insomnia: bibliotherapy with and without professional guidance. J Consult Clin Psychol. 1999;67:511-9. [PMID: 10450621]
27. van Straten A, Cuijpers P, Smit F, Spermon M, Verbeek I. Selfhelp treatment for insomnia through television and book: a randomized trial. Patient Educ Couns. 2009;74:29-34. [PMID: 18801639] doi: 10.1016/j.pec.2008.07.050
28. van Straten A, Emmelkamp J, de Wit J, Lancee J, Andersson G, van Someren EJ, et al. Guided Internet-delivered cognitive behavioural treatment for insomnia: a randomized trial. Psychol Med. 2014;44:1521-32. [PMID: 24001364] doi:10.1017/S0033291713002249
29. Bjorvatn B, Fiske E, Pallesen S. A self-help book is better than sleep hygiene advice for insomnia: a randomized controlled comparative study. Scand J Psychol. 2011;52:580-5. [PMID: 21790620] doi:10.1111/j.1467-9450.2011.00902.x
30. Edinger JD, Wohlgemuth WK, Radtke RA, Coffman CJ, Carney CE. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep. 2007;30:203-12. [PMID: 17326546]
31. Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39:45-60. [PMID: 11125723]
32. Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, et al. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment-a randomized trial. Behav Res Ther. 2015;71:90-100. [PMID: 26091917] doi:10.1016/j.brat.2015.06.001
33. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract. 2003;53:923-8. [PMID: 14960215]
34. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856-64. [PMID: 11308399]
35. Jansson-Fröjmark M, Linton SJ, Flink IK, Granberg S, Danermark B, Norell-Clarke A. Cognitive-behavioral therapy for insomnia comorbid with hearing impairment: a randomized controlled trial. J Clin Psychol Med Settings. 2012;19:224-34. [PMID: 22323041] doi: 10.1007/s10880-011-9275-y
36. Pigeon WR, Moynihan J, Matteson-Rusby S, Jungquist CR, Xia Y, Tu X, et al. Comparative effectiveness of CBT interventions for comorbid chronic pain & insomnia: a pilot study. Behav Res Ther. 2012; 50:685-9. [PMID: 22982083] doi:10.1016/j.brat.2012.07.005
37. Morin CM, Beaulieu-Bonneau S, LeBlanc M, Savard J. Self-help treatment for insomnia: a randomized controlled trial. Sleep. 2005; 28:1319-27. [PMID: 16295218]
38. Harris J, Lack L, Kemp K, Wright H, Bootzin R. A randomized controlled trial of intensive sleep retraining (ISR): a brief conditioning treatment for chronic insomnia. Sleep. 2012;35:49-60. [PMID: 22215918] doi:10.5665/sleep.1584
39. Espie CA, Lindsay WR, Brooks DN, Hood EM, Turvey T. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther. 1989;27:79-88. [PMID: 2914008]
40. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Breen EC, Witarama T, et al. Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep. 2014;37:1543-52. [PMID: 25142571] doi: 10.5665/sleep.4008
41. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281:991-9. [PMID: 10086433]
42. Morin CM, Kowatch RA, Barry T, Walton E. Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol. 1993;61:137-46. [PMID: 8450099]
43. Rybarczyk B, Stepanski E, Fogg L, Lopez M, Barry P, Davis A. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol. 2005;73:1164-74. [PMID: 16392989]
44. Morgan K, Gregory P, Tomeny M, David BM, Gascoigne C. Selfhelp treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial. J Am Geriatr Soc. 2012;60:1803-10. [PMID: 23035962] doi:10.1111/j.1532-5415.2012.04175.x
45. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295:2851-8. [PMID: 16804151]
46. Lovato N, Lack L, Wright H, Kennaway DJ. Evaluation of a brief treatment program of cognitive behavior therapy for insomnia in older adults. Sleep. 2014;37:117-26. [PMID: 24470701] doi:10.5665/sleep.3320
47. Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med. 2011;171:887-95. [PMID: 21263078] doi:10.1001/archinternmed.2010.535
48. McCrae CS, McGovern R, Lukefahr R, Stripling AM. Research Evaluating Brief Behavioral Sleep Treatments for Rural Elderly (RESTORE): a preliminary examination of effectiveness. Am J Geriatr Psychiatry. 2007;15:979-82. [PMID: 17974868]
49. Soeffing JP, Lichstein KL, Nau SD, McCrae CS, Wilson NM, Aguillard RN, et al. Psychological treatment of insomnia in hypnoticdependant older adults. Sleep Med. 2008;9:165-71. [PMID: 17644419]
50. Germain A, Moul DE, Franzen PL, Miewald JM, Reynolds CF 3rd, Monk TH, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med. 2006;2:403-6. [PMID: 17557467]
51. Epstein DR, Sidani S, Bootzin RR, Belyea MJ. Dismantling multicomponent behavioral treatment for insomnia in older adults: a randomized controlled trial. Sleep. 2012;35:797-805. [PMID: 22654199] doi:10.5665/sleep.1878
52. Morin CM, Azrin NH. Behavioral and cognitive treatments of geriatric insomnia. J Consult Clin Psychol. 1988;56:748-53. [PMID: 3192792]
53. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26:793-9. [PMID: 14655910]
54. Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30:959-68. [PMID: 17702264]
55. Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin. 2004;20:1979-91. [PMID: 15701215]
56. Elie R, Rü ther E, Farr I, Emilien G, Salinas E. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry. 1999;60:536-44. [PMID: 10485636]
57. Fry J, Scharf M, Mangano R, Fujimori M. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group. Int Clin Psychopharmacol. 2000;15: 141-52. [PMID: 10870872]
58. Randall S, Roehrs TA, Roth T. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep. 2012;35: 1551-7. [PMID: 23115404] doi:10.5665/sleep.2208
59. Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebocontrolled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry. 1994;55:192-9. [PMID: 8071269]
60. Lahmeyer H, Wilcox CS, Kann J, Leppik I. Subjective efficacy of zolpidem in outpatients with chronic insomnia. Clin Drug Investig. 1997;13:134-44. doi:10.2165/00044011-199713030-00003
61. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164: 1888-96. [PMID: 15451764]
62. Allain H, Arbus L, Schü ck S; Zolpidem Study Group. Efficacy and safety of zolpidem administered 'as needed' in primary insomnia. Clin Drug Investig. 2001;21:391-400. doi:10.2165/00044011-200121060-00001
63. Perlis ML, McCall WV, Krystal AD, Walsh JK. Long-term, nonnightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry. 2004;65:1128-37. [PMID: 15323600]
64. Walsh JK. Zolpidem "as needed" for the treatment of primary insomnia: a double-blind, placebo-controlled study. Sleep Med Rev. 2002;6 Suppl 1:S7-10. [PMID: 12607571]
65. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extendedrelease 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31:79-90. [PMID: 18220081]
66. Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study. Sleep. 2013;36:189-96. [PMID: 23372266] doi:10.5665/sleep.2370
67. Herring WJ, Connor KM, Ivgy-May N, Snyder E, Liu K, Snavely DB, et al. Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials. Biol Psychiatry. 2016; 79:136-48. [PMID: 25526970] doi:10.1016/j.biopsych.2014.10.003
68. Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep. 2011;34:1433-42. [PMID: 21966075] doi:10.5665/SLEEP.1294
69. Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, et al. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep. 2010;33:225-34. [PMID: 20175406]
70. Leppik IE, Roth-Schechter GB, Gray GW, Cohn MA, Owens D. Double-blind, placebo-controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia. Drug Dev Res. 1997;40:230-8. doi:10.1002/(SICI)1098-2299(199703)40:3〈230::AID-DDR3〉3.0.CO;2-L
71. Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med. 2006;7:312-8. [PMID: 16709464]
72. Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, et al. Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep. 2010;33:1553-61. [PMID: 21102997]
73. Lankford A, Rogowski R, Essink B, Ludington E, Heith Durrence H, Roth T. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med. 2012;13:133-8. [PMID: 22197474] doi:10.1016/j.sleep.2011.09.006
74. Chen PL, Lee WJ, Sun WZ, Oyang YJ, Fuh JL. Risk of dementia in patients with insomnia and long-term use of hypnotics: a populationbased retrospective cohort study. PLoS One. 2012;7:e49113. [PMID: 23145088] doi:10.1371/journal.pone.0049113
75. Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med PublicHealth.2012;45:219-26.[PMID:22880153]doi:10.3961/jpmph.2012.45.4.219
76. Lai MM, Lin CC, Lin CC, Liu CS, Li TC, Kao CH. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc. 2014;89:589-94. [PMID: 24684782] doi: 10.1016/j.mayocp.2014.01.021
77. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2: e000850. [PMID: 22371848] doi:10.1136/bmjopen-2012-000850
78. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.
79. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions. Methods Guide for Comparative Effectiveness Reviews. AHRQ publication no. 12-EHC047-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
80. White CM, Ip S, McPheeters M, Carey TS, Chou R, Lohr KN, et al. Using Existing Systematic Reviews to Replace De Novo Processes in Conducting Comparative Effectiveness Reviews. Methods Guide for Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2009.